A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 27, 2016

Primary Completion Date

August 22, 2018

Study Completion Date

August 22, 2018

Conditions
Melanoma
Interventions
DRUG

Cobimetinib

Participants will receive cobimetinib as per local guidelines and/or routine clinical practice.

DRUG

Vemurafenib

Participants will receive vemurafenib as per local guidelines and/or routine clinical practice.

Trial Locations (33)

13385

Hopital Timone Adultes; Dermatologie, Marseille

21000

Centre Georges Francois Leclerc, Dijon

21079

Chu Site Du Bocage;Dermatologie, Dijon

25030

CHU Besançon - Hôpital Jean Minjoz, Besançon

26953

Centre Hospitalier Valence, Valence

31059

CHU de Toulouse - Hôpital Larrey, Toulouse

34295

Hopital Saint Eloi; CHU de Montpellier; Svc de Dermatologie, Montpellier

35000

Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer, Rennes

35403

Hopital Broussais, St-Malo

42055

CHU de Saint-Etienne - Hopital Nord, Saint-Etienne

57126

Hopital Bel Air, Thionville

59037

Hopital Claude Huriez; Sce Dermatologie, Lille

63003

Chu Estaing; Dermatologie, Clermont-Ferrand

64109

Chic Cote Basque Bayonne; Medecine II, Bayonne

67000

Pole de Cancerologie Prive Strasbourgeois, Strasbourg

68024

Hopital Louis Pasteur; Sce Dermatologie, Colmar

68070

CH de Mulhouse Hôpital Emile Muller, Mulhouse

72037

Centre Hospitalier Le Mans; Dermatologie, Le Mans

73011

CH Metropole de Savoie, Chambéry

75006

Hopital Cochin; Dermatologie, Paris

75018

Groupe Hospitalier Bichat Claude Bernard, Paris

76031

CHU Rouen - CH C. Nicolle - Clinique dermatologique, Rouen

76290

Hopital Jacques Monod; Dermatologie, Montivilliers

81013

Centre Hospitalier d'Albi, Albi

83041

Hia Sainte Anne; Medecine Interne Oncologie, Toulon

87042

CHU de Limoges - Hôpital Dupuytren, Limoges

92166

Hopital Prive D Antony; Dermatologie, Antony

93009

Hopital Avicenne; Dermatologie, Bobigny

94805

Institut Gustave Roussy; Dermatologie, Villejuif

01000

CH Fleyriat, Bourg-en-Bresse

06200

Hopital l Archet 2; Ginestriere, Service de; Dermatologie, Nice

Unknown

CENTRE HOSPITALIER ANNECY-GENEVOIS; Dematologie, Pringy

07810

CHI de Poissy St Germain, Saint-Germain

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03139513 - A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU]) | Biotech Hunter | Biotech Hunter